YKL-40 and genetic status of CHI3L1 in a large group of asthmatics
… We studied the relationship between clinical asthma … Short-acting inhaled bronchodilators
should be discontinued for … be a biomarker of both acute and chronic inflammatory activity. We …
should be discontinued for … be a biomarker of both acute and chronic inflammatory activity. We …
Peripheral blood gene expression predicts clinical benefit from anti–IL-13 in asthma
DF Choy, G Jia, AR Abbas, KB Morshead… - Journal of Allergy and …, 2016 - jacionline.org
… from type 2 pathway–directed therapies in pediatric asthma is … novel associations in vivo
with respect to asthmatic type 2 … obstruction with a short-acting bronchodilator or methacholine …
with respect to asthmatic type 2 … obstruction with a short-acting bronchodilator or methacholine …
THE EFFECTS OF RARE GENETIC VARIANTS AND GENETIC ANCESTRY ON DRUG RESPONSE AND SEVERITY IN AIRWAYS DISEASES
VE Ortega - 2016 - wakespace.lib.wfu.edu
… for asthma and exist as three drug classes: short-acting beta … , associated with acute
bronchodilator response to albuterol … polymorphisms (SNPs) to test for associations with asthma …
bronchodilator response to albuterol … polymorphisms (SNPs) to test for associations with asthma …
Therapeutic implications of beta-adrenergic receptor pharmacodynamic properties
CA Taira, A Carranza, M Mayer… - Current Clinical …, 2008 - ingentaconnect.com
… However, several studies using short-acting or long-acting … Phosphodiesterase 4D is required
for β2 adrenoceptor subtype-… of the β2-adrenoceptor and response to albuterol in children …
for β2 adrenoceptor subtype-… of the β2-adrenoceptor and response to albuterol in children …
Leukotrienes
M Peters-Golden… - New England Journal of …, 2007 - Mass Medical Soc
… to type 1 cysteinyl leukotriene receptor (CysLT 1 ) in asthma … in myriad cellular and tissue
responses. The sites of action of … membrane is associated with a maximal synthesis of LTB 4 . …
responses. The sites of action of … membrane is associated with a maximal synthesis of LTB 4 . …
Effects of asthma treatment: the present and future
GP Currie - Expert Review of Clinical Immunology, 2006 - Taylor & Francis
… In patients with mild intermittent asthma, a short acting β 2 -… This all implies that in the clinical
setting of an acute asthma … will be able to perceive a relatively quick onset of bronchodilation…
setting of an acute asthma … will be able to perceive a relatively quick onset of bronchodilation…
Respiratory Disorders of the Immune System and Their Pharmacological Treatment
CB Mathias - Pharmacology of Immunotherapeutic Drugs, 2020 - Springer
… , some patients have intrinsic asthma, which is not associated … While short-acting β 2 -agonists
such as albuterol are frequently … In patients with acute severe asthma, it is effective when …
such as albuterol are frequently … In patients with acute severe asthma, it is effective when …
The role of magnesium in the treatment of acute asthma in adults and its effects on beta-2 adrenergic receptor function
M Busuttil - 2019 - digital.library.adelaide.edu.au
… Short acting beta agonist SERCA … In HASM, cAMP is rapidly degraded by the enzyme
phosphodiesterase 4D … important in asthma as the target of β-2 agonist bronchodilator treatment. …
phosphodiesterase 4D … important in asthma as the target of β-2 agonist bronchodilator treatment. …
[PDF][PDF] Polymorphisms of Interleukin 13 (IL13) in Local Asthmatic Population
A Hasnain - University Of Health Sciences Lahore, 2008 - uhs.edu.pk
… 13 gene polymorphisms and their association with asthma and … an estimated 4.3% children
suffer from asthma in Pakistan. … bronchodilators and increased use of systemic steroids [34]. …
suffer from asthma in Pakistan. … bronchodilators and increased use of systemic steroids [34]. …
[HTML][HTML] Effects of dual therapy with corticosteroids plus long acting β2-agonists in asthma
GP Currie, DKC Lee, AM Wilson - Respiratory medicine, 2005 - Elsevier
… admissions and risks associated with an acute exacerbation, … of an acute asthma attack, it
may be relevant that a blunted … of 15% to short acting bronchodilator, irrespective of extent of …
may be relevant that a blunted … of 15% to short acting bronchodilator, irrespective of extent of …